Get the Stockscreener App
0.7606
3.73%
-0.0295
After Hours:
.71
-0.0506
-6.65%
Cue Biopharma Inc Stock (CUE) Forecast
The Cue Biopharma Inc (CUE) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $11.82, representing a +1,454% increase from the current price of $0.7606. The highest analyst price target is $16.86, and the lowest is $6.7898.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month CUE Price Target
Average 16.26
(+2,038% Upside)
Is Cue Biopharma Inc (CUE) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 27.37 | Buy |
| STOCH(9,6) | 21.42 | Neutral |
| STOCHRSI(14) | 20.53 | Neutral |
| MACD(12,26) | -0.0993 | Sell |
| ADX(14) | 28.13 | Sell |
| William %R | -83.88 | Buy |
| CCI(14) | -154.57 | Sell |
Buy: 2
Sell: 3
Neutral: 2
Summary: Sell
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.9137
Sell
|
0.8806
Sell
|
| MA20 |
0.9546
Sell
|
0.96
Sell
|
| MA50 |
1.1782
Sell
|
1.0902
Sell
|
| MA100 |
1.201
Sell
|
1.1516
Sell
|
| MA200 |
1.076
Sell
|
1.3188
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, CUE could be considered a Strong Sell, with 17 technical analysis indicators signaling 2 Buy signals, 13 signaling Sell signals and 2 Neutral signals. This might not be a good time to consider opening new positions on CUE, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 27.37 indicates that CUE is oversold. This indicates that CUE price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
- STOCH (Stochastic Oscillator): The STOCH value of 21.42 indicates that CUE is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 20.53 indicates that CUE is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 28.13 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -154.57 indicates that CUE is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term CUE price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Cue Biopharma Inc financial reports and earnings history, Cue Biopharma Inc (CUE) stock could reach $3.4031 by 2030, $3.8124 by 2040 and $11.89 by 2050. See the projected annual prices until 2050 of the Cue Biopharma Inc stock below:
- Cue Biopharma Inc (CUE) is expected to reach an average price of $1.3531 in 2035, with a high prediction of $1.80 and a low estimate of $1.4631. This indicates an $77.90% rise from the last recorded price of $0.7606.
- Cue Biopharma Inc (CUE) stock is projected to chart a bullish course in 2040, with an average price target of $2.9773, representing an $291.43% surge from its current level. The forecast ranges from a conservative $3.6973 to a sky-high $3.8124.
- Our analysts predict Cue Biopharma Inc (CUE) to jump 1,055% by 2045, soaring from $9.0267 to an average price of $8.7864, potentially reaching $9.1398. While $9.0267 is the low estimate, the potential upside is significant.
- Cue Biopharma Inc (CUE) stock is expected to climb by 2050, reaching an average of $11.83, a $1,456% jump from its current level. However, a wide range of estimates exists, with high and low targets of $11.89 and $12.03, respectively, highlighting the market's uncertainty.
Cue Biopharma Inc Stock (CUE) Year by Year Forecast
Cue Biopharma Inc Stock (CUE) Price Forecast for 2025
Cue Biopharma Inc Stock (CUE) is expected to reach an average price of $15.25 in 2025, with a high prediction of $26.52 and a low estimate of $3.9771. This indicates an +1,905% rise from the last recorded price of $0.7606.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| May, 2025 | $16.49 | $6.7898 | $16.86 | +2,068% |
| June, 2025 | $21.02 | $17.47 | $23.17 | +2,663% |
| July, 2025 | $19.56 | $18.88 | $26.52 | +2,472% |
| August, 2025 | $17.31 | $16.32 | $21.36 | +2,176% |
| September, 2025 | $14.89 | $13.15 | $18.59 | +1,857% |
| October, 2025 | $10.92 | $9.0661 | $17.55 | +1,335% |
| November, 2025 | $10.19 | $9.5737 | $13.55 | +1,240% |
| December, 2025 | $6.3889 | $5.9989 | $12.45 | +739.98% |
Cue Biopharma Inc Stock (CUE) Price Forecast for 2026
The predicted value for Cue Biopharma Inc (CUE) in 2026 is set at an average of $8.931. Estimates vary from a peak of $12.25 to a trough of $5.6144, indicating an +1,074% surge from the present price of $0.7606.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $9.0523 | $6.2247 | $9.5123 | +1,090% |
| February, 2026 | $8.6557 | $7.7257 | $9.804 | +1,038% |
| March, 2026 | $8.0492 | $7.2974 | $9.1816 | +958.27% |
| April, 2026 | $9.4785 | $8.0909 | $12.25 | +1,146% |
| May, 2026 | $10.01 | $6.9502 | $11.45 | +1,216% |
| June, 2026 | $7.9253 | $6.3641 | $10.37 | +941.98% |
| July, 2026 | $9.3946 | $6.3988 | $11.51 | +1,135% |
| August, 2026 | $9.1081 | $8.6722 | $10.63 | +1,097% |
| September, 2026 | $7.2074 | $6.6243 | $9.5539 | +847.59% |
| October, 2026 | $6.7008 | $5.7482 | $7.4382 | +780.99% |
| November, 2026 | $7.9842 | $5.6144 | $8.9442 | +949.73% |
| December, 2026 | $10.63 | $7.2259 | $11.85 | +1,297% |
Cue Biopharma Inc Stock (CUE) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Cue Biopharma Inc (CUE) is $7.33, with a high forecast of $14.62 and a low forecast of $0.0397. This indicates an +863.72% increase from the last price of $0.7606.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $8.057 | $7.637 | $10.90 | +959.29% |
| February, 2027 | $11.03 | $7.8559 | $14.62 | +1,350% |
| March, 2027 | $8.0897 | $6.5497 | $11.08 | +963.59% |
| April, 2027 | $6.2931 | $5.6631 | $9.1014 | +727.39% |
| May, 2027 | $3.2866 | $2.9548 | $7.6048 | +332.10% |
| June, 2027 | $1.4958 | $1.4358 | $3.8933 | +96.67% |
| July, 2027 | $1.4293 | $0.8076 | $2.5076 | +87.92% |
| August, 2027 | $1.0327 | $0.7227 | $2.871 | +35.78% |
| September, 2027 | $0.552 | $0.0397 | $1.1286 | -27.42% |
| October, 2027 | $0.3346 | $0.0596 | $0.9237 | -56.01% |
| November, 2027 | $0.3211 | $0.3587 | $0.597 | -57.78% |
| December, 2027 | $0.2682 | $0.3018 | $0.3735 | -64.74% |
Cue Biopharma Inc Stock (CUE) Price Forecast for 2028
In 2028, Cue Biopharma Inc (CUE) is projected to reach an average price of $1.3613, with a high projection of $2.716 and a low estimate of $0.00667. This indicates an +78.98% rise from the last price of $0.7606.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.0516 | $0.106 | $0.334 | -93.21% |
| February, 2028 | $0.745 | $0.00667 | $0.3933 | -2.06% |
| March, 2028 | $0.2357 | $0.2957 | $0.4209 | -69.02% |
| April, 2028 | $0.6878 | $0.0561 | $1.1519 | -9.57% |
| May, 2028 | $0.00293 | $0.1188 | $1.3895 | -99.62% |
| June, 2028 | $0.8005 | $0.0946 | $1.0246 | +5.25% |
| July, 2028 | $0.7639 | $0.5122 | $1.1739 | +0.44% |
| August, 2028 | $0.1368 | $0.0715 | $0.8898 | -82.02% |
| September, 2028 | $0.8967 | $0.1709 | $1.2067 | +17.89% |
| October, 2028 | $2.4701 | $0.5625 | $2.60 | +224.76% |
| November, 2028 | $1.7694 | $1.2578 | $2.716 | +132.63% |
| December, 2028 | $1.3728 | $1.2278 | $1.9253 | +80.49% |
Cue Biopharma Inc Stock (CUE) Price Forecast for 2029
The 2029 price forecast for Cue Biopharma Inc Stock (CUE) is $1.8471 on average, with a high prediction of $3.68 and a low estimate of $0.0141. This represents an +142.84% increase from the previous price of $0.7606.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $1.6221 | $1.1887 | $2.6604 | +113.27% |
| February, 2029 | $0.6556 | $0.4956 | $1.718 | -13.81% |
| March, 2029 | $0.489 | $0.4631 | $0.7914 | -35.71% |
| April, 2029 | $0.0424 | $0.0434 | $0.5207 | -94.42% |
| May, 2029 | $0.3817 | $0.0141 | $0.9117 | -49.81% |
| June, 2029 | $0.5352 | $0.2693 | $0.8093 | -29.64% |
| July, 2029 | $0.8386 | $0.5278 | $1.4001 | +10.26% |
| August, 2029 | $0.9179 | $0.7645 | $1.4303 | +20.68% |
| September, 2029 | $0.3513 | $0.2913 | $0.9838 | -53.81% |
| October, 2029 | $0.3206 | $0.1748 | $0.7272 | -57.85% |
| November, 2029 | $0.0441 | $0.0459 | $0.5482 | -94.21% |
| December, 2029 | $4.21 | $0.1142 | $3.68 | +453.51% |
Cue Biopharma Inc Stock (CUE) Price Forecast for 2030
Cue Biopharma Inc Stock (CUE) is expected to reach an average price of $6.1746 in 2030, with a high forecast of $12.08 and a low forecast of $0.2684. This signifies an +711.80% surge from the last price of $0.7606.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $3.9783 | $4.0248 | $3.4031 | +423.05% |
| February, 2030 | $5.1145 | $4.1163 | $3.873 | +572.44% |
| March, 2030 | $3.6777 | $3.8077 | $4.1411 | +383.52% |
| April, 2030 | $3.5308 | $4.2225 | $3.4708 | +364.21% |
| May, 2030 | $3.0322 | $2.9456 | $3.2891 | +298.66% |
| June, 2030 | $3.0553 | $4.0988 | $3.9671 | +301.70% |
| July, 2030 | $1.2368 | $2.5068 | $2.7636 | +62.60% |
| August, 2030 | $4.8651 | $0.2684 | $6.3301 | +539.64% |
| September, 2030 | $4.737 | $2.357 | $6.9018 | +522.80% |
| October, 2030 | $6.2956 | $3.1804 | $9.6456 | +727.71% |
| November, 2030 | $1.8124 | $1.3224 | $12.08 | +138.29% |
| December, 2030 | $1.8893 | $1.0459 | $4.5659 | +148.40% |
1.23%
1.63%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):